Amylyx Pharmaceuticals, Inc. company logo
Amylyx Pharmaceuticals, Inc. logo

Amylyx Pharmaceuticals, Inc. (AMLX) Cash From Financing

Annual CFF

$348.00K$3.20M-90.18%

Summary

Current Value
As of today, AMLX annual cash from financing is $348.00K, down -90.18% on
Historical Performance
AMLX annual cash from financing is down -99.78% over the past 3 years, and down -47.90% over the past 5 years
All-Time High Comparison
AMLX annual cash from financing is currently -99.92% below its historical high of $431.79M set on
3-Year Low Comparison
AMLX annual cash from financing is at its 3-year low
Sector Comparison
AMLX annual cash from financing is higher than 29.93% of companies in Healthcare sector

Cash From Financing Chart

Add series to chart
Add series to chart1/6
Series
SUGGESTED SERIES

Performance

AMLX Performance
MetricDateValue1Y3Y5Y15Y
Annual Cash From Financing$348.00K-90.2%-99.8%-47.9%-47.9%
Quarterly Cash From Financing$191.61M+10000.0%+100.0%
TTM Cash From Financing$257.35M+10000.0%+29.6%
Price$16.92+390.4%-54.1%
Annual Cash From Operations-$167.65M-1506.5%-124.1%-1468.7%-1468.7%
Annual Cash From Investing$75.65M-17.8%+263.0%+100.0%+100.0%
Annual Dividends Paid$0.000.0%0.0%0.0%0.0%
Annual Total Debt$1.98M-53.3%+100.0%-86.7%-86.7%
Shares Outstanding109.82M+24.3%+65.1%+94.5%

Cash From Financing Highs

AMLX Annual Cash From Financing Highs Comparison
PeriodHighDateCurrent
3Y$431.79MN/A-99.9%
5Y$431.79M-99.9%
All$431.79M-99.9%

Cash From Financing Lows

AMLX Annual Cash From Financing Lows Comparison
PeriodLowDateCurrent
3Y$348.00Kat low
5Y$348.00Kat low
All$348.00Kat low

Cash From Financing History

YearValueChange
$348.00K-90.2%
$3.54M-99.2%
$431.79M+172.4%
YearValueChange
$158.51M+238.5%
$46.82M+6,909.4%
$668.00K-

FAQ

  • What is the current annual cash from financing of AMLX?

    As of today, AMLX annual cash from financing is $348.00K

  • What is 1-year change in AMLX annual cash from financing?

    AMLX annual cash from financing is down -90.18% year-over-year

  • What is 3-year change in AMLX annual cash from financing?

    AMLX annual cash from financing is down -99.78% over the past 3 years

  • How far is AMLX annual cash from financing from its all-time high?

    AMLX annual cash from financing is currently -99.92% below its historical high of $431.79M set on December 31, 2022

  • How does AMLX annual cash from financing rank versus sector peers?

    AMLX annual cash from financing is higher than 29.93% of companies in Healthcare sector

  • When is AMLX next annual earnings release?

    The next annual earnings release for AMLX is on

Cash From Financing Formula

CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities

Data Sources & References

  1. AMLX Official Website amylyx.com
  2. Most Recent Quarterly Report (10-Q) www.sec.gov/Archives/edgar/data/1658551/000119312525268059/0001193125-25-268059-index.htm
  3. Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1658551/000095017025031309/0000950170-25-031309-index.htm
  4. AMLX Profile on Yahoo Finance finance.yahoo.com/quote/AMLX
  5. AMLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amlx